R. Michael Carruthers, Executive Vice President / CFO at Nivalis Therapeutics, Inc. (NVLS), bought 24,000 shares at $2.09 ($50K) on 2016-12-02, disclosed to the SEC on 2016-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EWTX | SELL | 2024-09-24 | $5.7M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $41K | — | Filing → |
| EWTX | SELL | 2024-01-25 | $1.4M | — | Filing → |